Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Disorder 5Smoking Cessation 5Smoking 4Lung Neoplasms 4Uterine Cervical Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tobacco Use 2Small Cell Lung Carcinoma 2Head and Neck Neoplasms 2Cigarette Smoking 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Tobacco Use Cessation 1Tobacco Smoking 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Varenicline 1Tobacco Use Cessation Devices 1Nicotine Chewing Gum 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Behavior, Addictive × Tobacco Use Cessation Devices × Clear all
NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed
126 enrolled

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡